BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9270972)

  • 1. Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.
    Peluso MR; Dixon JL
    Lipids; 1997 Aug; 32(8):811-23. PubMed ID: 9270972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
    Avramoglu RK; Cianflone K; Sniderman AD
    J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
    Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
    Dashti N
    J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells.
    Sniderman AD; Zhang Z; Genest J; Cianflone K
    J Lipid Res; 2003 Mar; 44(3):527-32. PubMed ID: 12562860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
    Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
    J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
    Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
    Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver.
    Tarugi P; Nicolini S; Ballarini G; Marchi L; Duvigneau C; Tartoni P; Calandra S
    J Lipid Res; 1996 Mar; 37(3):493-507. PubMed ID: 8728313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.
    Sakata N; Wu X; Dixon JL; Ginsberg HN
    J Biol Chem; 1993 Nov; 268(31):22967-70. PubMed ID: 8226809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B.
    Dixon JL; Furukawa S; Ginsberg HN
    J Biol Chem; 1991 Mar; 266(8):5080-6. PubMed ID: 1848237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells.
    Furukawa S; Sakata N; Ginsberg HN; Dixon JL
    J Biol Chem; 1992 Nov; 267(31):22630-8. PubMed ID: 1429611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.
    Wu X; Shang A; Jiang H; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3347-55. PubMed ID: 9409332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
    Borradaile NM; de Dreu LE; Barrett PH; Huff MW
    J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms.
    Wu X; Sakata N; Dixon J; Ginsberg HN
    J Lipid Res; 1994 Jul; 35(7):1200-10. PubMed ID: 7964181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
    Wu X; Sakata N; Lui E; Ginsberg HN
    J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a "secretion-coupled" pool.
    Wu X; Shang A; Jiang H; Ginsberg HN
    J Lipid Res; 1996 Jun; 37(6):1198-206. PubMed ID: 8808754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2).
    Haghpassand M; Wilder D; Moberly JB
    J Lipid Res; 1996 Jul; 37(7):1468-80. PubMed ID: 8827519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation.
    White AL; Graham DL; LeGros J; Pease RJ; Scott J
    J Biol Chem; 1992 Aug; 267(22):15657-64. PubMed ID: 1639804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.
    Kaptein A; de Wit EC; Princen HM
    Arterioscler Thromb; 1994 May; 14(5):780-9. PubMed ID: 8172854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors.
    Kempen HJ; Imbach AP; Giller T; Neumann WJ; Hennes U; Nakada N
    J Lipid Res; 1995 Aug; 36(8):1796-806. PubMed ID: 7595100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.